Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CA | P42336 | 1/20 | 0.32 |
| ▸ | AKT1 | P31749 | 1/20 | 0.30 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15977711 | 0.87 | PDK2 (0.34) | MEN1LMNAKMT2A | |
| SCHEMBL15977911 | 0.84 | PDK2 (0.36) | MEN1LMNAKMT2A | |
| SCHEMBL19009627 | 0.82 | SMN1; SMN2 (0.36) | PIK3CACLK4MEN1LMNAHPGD | |
| SCHEMBL10301024 | 0.82 | CLK4 (0.41) | PIK3CACLK4MEN1LMNAHPGD | |
| SCHEMBL29393750 | 0.81 | MEN1 (0.46) | CLK4MEN1LMNAKMT2ADYRK1A | |
| SCHEMBL15977564 | 0.81 | CLK4 (0.40) | PIK3CACLK4MEN1KMT2ADYRK1A | |
| SCHEMBL10301065 | 0.81 | CLK4 (0.42) | PIK3CACLK4MEN1KMT2ADYRK1A | |
| SCHEMBL15977891 | 0.79 | NPC1 (0.42) | PIK3CACLK4 | |
| SCHEMBL13158613 | 0.79 | PIK3CA (0.40) | PIK3CAMEN1KMT2A | |
| SCHEMBL15977696 | 0.79 | NPC1 (0.42) | PIK3CACLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO.,LTD. (JP) | 2022-12-29 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-9559311-B2 | Anthracene derivative, organic-electroluminescence-device material, organic electroluminescence device, and electronic equipment | IDEMITSU KOSAN CO., LTD. (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
| US-20140239273-A1 | ANTHRACENE DERIVATIVE, ORGANIC-ELECTROLUMINESCENCE-DEVICE MATERIAL, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC EQUIPMENT | IDEMITSU KOSAN CO., LTD. (JP) | 2014-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220416178-A1 | COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS | PIEZO1, TMEM109, SLC39A14 | PIK3CA 2722/4885AKT1 3205/4885CLK4 1690/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.